---
figid: PMC9175269__mmr-26-01-12736-g01
pmcid: PMC9175269
image_filename: mmr-26-01-12736-g01.jpg
figure_link: /pmc/articles/PMC9175269/figure/f2-mmr-26-01-12736/
number: Figure 2
figure_title: ''
caption: 'Tranilast reduces LPS-induced pro-inflammatory cytokine release in the BEAS-2B
  cells. The mRNA and protein expression level of TNF-α, IL-1β, IL-6, COX2 and iNOS
  in LPS-stimulated BEAS-2B cells pretreated with different concentrations of tranilast
  was detected using (A) reverse transcription-quantitative PCR and (B) western blot
  analysis, respectively. ***P<0.001 vs. control; #P<0.05, ##P<0.01, ###P<0.001 vs.
  LPS. LPS, lipopolysaccharide; COX2, cytochrome c oxidase subunit II; iNOS, inducible
  nitric oxide.'
article_title: Tranilast attenuates lipopolysaccharide-induced lung injury via the
  CXCR4/JAK2/STAT3 signaling pathway.
citation: Yufeng Lou, et al. Mol Med Rep. 2022 Jul;26(1):220.
year: '2022'

doi: 10.3892/mmr.2022.12736
journal_title: Molecular Medicine Reports
journal_nlm_ta: Mol Med Rep
publisher_name: D.A. Spandidos

keywords:
- tranilast
- sepsis
- lung injury
- CXCR4
- inflammatory response

---
